Home » FDA postpones panel date for Contura's Aquamid wrinkle treatment
Welcome: Login | Register

FDA postpones panel date for Contura's Aquamid wrinkle treatment

October 20, 2011 by MassDevice staff

The Dec. 1 panel date for Contura's Aquamid wrinkle filler gets pushed back as the FDA mulls over new data.

Contura
FDA

The FDA pushed back a public hearing for Contura Inc.'s Aquamid dermal filler so that it "can review and consider additional information that was submitted."

Aquamid was set for pre-market approval review before the watchdog agency's General and Plastic Surgery Devices panel on Dec. 1.

A new hearing date has yet to be announced.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

News Well, Cosmetic/Aesthetic, Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance
Permalink
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp